Sulfatides inhibit adhesion, migration, and invasion of murine melanoma B16F10 cell line in vitro

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 11, 2012, Pages 2054-2058

  Ozawa, Hiroki ^a   Sonoda, Yoshiko ^a   Kato, Saori ^a   Suzuki, Erika ^a   Matsuoka, Ryotaro ^a   Kanaya, Takayuki ^a,b   Kiuchi, Fumiyuki ^a   Hada, Noriyasu ^a   Kasahara, Tadashi ^a  

^a KEIO UNIVERSITY   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Adhesion; Invasion; Melanoma; Motility; Sulfatide

Indexed keywords

3 SULFATED GLUCOSYLCERAMIDE; 6 SULFATED GLUCOSYLCERAMIDE; ALPHA5 INTEGRIN; BETA1 INTEGRIN; BETA3 INTEGRIN; CD51 ANTIGEN; FIBRONECTIN; FOCAL ADHESION KINASE; GLUCOSYLCERAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL LINE B16F10; CELL MIGRATION; CELL MOTILITY; CIONA INTESTINALIS; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; IN VITRO STUDY; MELANOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

ANIMALS; ANTIGENS, CD29; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBRONECTINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; INTEGRIN ALPHA5; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; SULFOGLYCOSPHINGOLIPIDS;

EID: 84869215585     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00492     Document Type: Article

References (24)

1. Takahashi T, Suzuki T. Role of sulfatide in normal and pathological cells and tissues. J. Lipid Res., 53, 1437-1450 (2012).
2. Higashi H, Suzuki Y, Mukaida N, Takahashi N, Miyamoto D, Matsushima K. Intervention in endotoxin shock by sulfatide (I3SO3-Ga1Cer) with a concomitant reduction in tumor necrosis factor alpha production. Infect. Immun., 65, 1223-1227 (1997).
3. Garcia J, Callewaert N, Borsig L. P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. Glycobiology, 17, 185-196 (2007).
4. Simonis D, Schlesinger M, Seelandt C, Borsig L, Bendas G. Analysis of SM4 sulfatide as a P-selectin ligand using model membranes. Biophys. Chem., 150, 98-104 (2010).
5. Kobayashi T, Honke K, Kuramitsu Y, Hosokawa M, Miyazaki T, Murata J, Saiki I, Ishizuka I, Makita A. Cell-surface sulfoglycolipids are involved in the attachment of renal-cancer cells to laminin. Int. J. Cancer, 56, 281-285 (1994).
6. Zhong Wu X, Honke K, Long Zhang Y, Liang Zha X, Taniguchi N. Lactosylsulfatide expression in hepatocellular carcinoma cells enhances cell adhesion to vitronectin and intrahepatic metastasis in nude mice. Int. J. Cancer, 110, 504-510 (2004).
7. Kabayama K, Ito N, Honke K, Igarashi Y, Inokuchi J. Suppression of integrin expression and tumorigenicity by sulfation of lactosylceramide in 3LL Lewis lung carcinoma cells. J. Biol. Chem., 276, 26777-26783 (2001).
8. Konno A, Nunogami K, Wada T, Yachie A, Suzuki Y, Takahashi N, Suzuki T, Miyamoto D, Kiso M, Hasegawa A, Miyawaki T. Inhibitory action of sulfatide, a putative ligand for L-selectin, on B cell proliferation and Ig production. Int. Immunol., 8, 1905-1913 (1996).
9. Mulligan MS, Warner RL, Lowe JB, Smith PL, Suzuki Y, Miyasaka M, Yamaguchi S, Ohta Y, Tsukada Y, Kiso M, Hasegawa A, Ward PA. In vitro and in vivo selectin-blocking activities of sulfated lipids and sulfated sialyl compounds. Int. Immunol., 10, 569-575 (1998).
10. Cui Y, Colsch B, Afonso C, Baumann N, Tabet JC, Mallet JM, Zhang Y. Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies. Glycoconj. J., 25, 147-155 (2008).
11. Sonoda Y, Warita M, Suzuki T, Ozawa H, Fukuda Y, Funakoshi-Tago M, Kasahara T. Proteolipid protein 2 is associated with melanoma metastasis. Oncol. Rep., 23, 371-376 (2010).
12. Liao CH, Sang S, Ho CT, Lin JK. Garcinol modulates tyrosine phosphorylation of FAK and subsequently induces apoptosis through down-regulation of Src, ERK, and Akt survival signaling in human colon cancer cells. J. Cell. Biochem., 96, 155-169 (2005).
13. Kim SA, Kwon SM, Kim JA, Kang KW, Yoon JH, Ahn SG. 5′-Nitro- indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin β1/FAK/Akt signaling. Cancer Lett., 306, 197-204 (2011).
14. Dia VP, Gonzalez de Mejia E. Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5/β1 integrin and suppresses FAK/ERK/NF-κB signaling. Cancer Lett., 313, 167-180 (2011).
15. Hakomori SI. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett., 584, 1901-1906 (2010).
16. Jeon SB, Yoon HJ, Park SH, Kim IH, Park EJ. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J. Immunol., 181, 8077-8087 (2008).
17. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat. Rev. Cancer, 2, 91-100 (2002).
18. 5 and fibronectin is required for metastasis of B16F10 melanoma cells. Biochem. Biophys. Res. Commun., 333, 1269-1275 (2005).
19. Sil H, Sen T, Chatterjee A. Fibronectin-integrin (α5β1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9. Oncol. Res., 19, 335-348 (2011).
20. Brandt DT, Baarlink C, Kitzing TM, Kremmer E, Ivaska J, Nollau P, Grosse R. SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin. Nat. Cell Biol., 11, 557-568 (2009).
21. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res., 67, 659-664 (2007).
22. Morichika H, Hamanaka Y, Tai T, Ishizuka I. Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer, 78, 43-47 (1996).
23. Makhlouf AM, Fathalla MM, Zakhary MA, Makarem MH. Sulfatides in ovarian tumors: clinicopathological correlates. Int. J. Gynecol Cancer, 14, 89-93 (2004).
24. McKenzie JA, Liu T, Goodson AG, Grossman D. Survivin enhances motility of melanoma cells by supporting Akt activation and α5 integrin upregulation. Cancer Res., 70, 7927-7937 (2010).